{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,5,15]],"date-time":"2025-05-15T00:40:10Z","timestamp":1747269610797,"version":"3.40.5"},"reference-count":28,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,5,15]],"date-time":"2025-05-15T00:00:00Z","timestamp":1747267200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,5,15]],"date-time":"2025-05-15T00:00:00Z","timestamp":1747267200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["npj Genom. Med."],"DOI":"10.1038\/s41525-025-00476-6","type":"journal-article","created":{"date-parts":[[2025,5,14]],"date-time":"2025-05-14T23:58:59Z","timestamp":1747267139000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Myelodysplastic syndrome diagnosed by genetic testing for hereditary cancer: a case report"],"prefix":"10.1038","volume":"10","author":[{"given":"Sarah","family":"Ridd","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0006-0551-7940","authenticated-orcid":false,"given":"Larissa","family":"Peck","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aniket","family":"Bankar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5937-9276","authenticated-orcid":false,"given":"George S.","family":"Charames","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jordan","family":"Lerner-Ellis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Radhika","family":"Mahajan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Peter J. B.","family":"Sabatini","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrew","family":"Wong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Janet","family":"Malcolmson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2147-8674","authenticated-orcid":false,"given":"Raymond H.","family":"Kim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,5,15]]},"reference":[{"key":"476_CR1","doi-asserted-by":"publisher","first-page":"699","DOI":"10.1007\/s13311-014-0288-8","volume":"11","author":"K Lohmann","year":"2014","unstructured":"Lohmann, K. & Klein, C. Next generation sequencing and the future of genetic diagnosis. Neurotherapeutics 11, 699\u2013707 (2014).","journal-title":"Neurotherapeutics"},{"key":"476_CR2","doi-asserted-by":"publisher","first-page":"1179","DOI":"10.1038\/s41436-021-01138-5","volume":"23","author":"EC Chao","year":"2021","unstructured":"Chao, E. C. et al. Incidental detection of acquired variants in germline genetic and genomic testing: a points to consider statement of the American College of Medical Genetics and Genomics (ACMG). Genet. Med. 23, 1179\u20131184 (2021).","journal-title":"Genet. Med."},{"key":"476_CR3","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1016\/j.cancergen.2017.01.002","volume":"211","author":"B Coffee","year":"2017","unstructured":"Coffee, B. et al. Detection of somatic variants in peripheral blood lymphocytes using a next generation sequencing multigene pan cancer panel. Cancer Genet. 211, 5\u20138 (2017).","journal-title":"Cancer Genet."},{"key":"476_CR4","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1016\/j.trecan.2019.11.006","volume":"6","author":"D Mandelker","year":"2020","unstructured":"Mandelker, D. & Ceyhan-Birsoy, O. Evolving significance of tumor-normal sequencing in cancer care. Trends Cancer 6, 31\u201339 (2020).","journal-title":"Trends Cancer"},{"key":"476_CR5","doi-asserted-by":"publisher","first-page":"100942","DOI":"10.1016\/j.gimo.2024.100942","volume":"2","author":"O Birsoy","year":"2024","unstructured":"Birsoy, O. et al. O12: Clonal hematopoiesis-related variants confounding hereditary cancer testing: Results from matched tumor-normal sequencing of 26,329 cancer patients. Genet. Med. Open 2, 100942 (2024).","journal-title":"Genet. Med. Open"},{"key":"476_CR6","doi-asserted-by":"crossref","unstructured":"Krystel-Whittemore, M. et al. Cell-free DNA from nail clippings as source of normal control for genomic studies in hematologic malignancies. Haematologica 109, 3269\u20133281 (2020).","DOI":"10.3324\/haematol.2024.285054"},{"key":"476_CR7","doi-asserted-by":"publisher","first-page":"5918","DOI":"10.1158\/1078-0432.CCR-18-1201","volume":"24","author":"CC Coombs","year":"2018","unstructured":"Coombs, C. C. et al. Identification of clonal hematopoiesis mutations in solid tumor patients undergoing unpaired next-generation sequencing assays. Clin. Cancer Res. 24, 5918 (2018).","journal-title":"Clin. Cancer Res."},{"key":"476_CR8","doi-asserted-by":"publisher","first-page":"219","DOI":"10.7150\/jca.79236","volume":"14","author":"J Huang","year":"2023","unstructured":"Huang, J. et al. The role of CTNNA1 in malignancies: an updated review. J. Cancer 14, 219\u2013230 (2023).","journal-title":"J. Cancer"},{"key":"476_CR9","doi-asserted-by":"publisher","first-page":"769","DOI":"10.1136\/jmg-2022-108945","volume":"60","author":"KA Bell","year":"2023","unstructured":"Bell, K. A. et al. Development of a comprehensive approach to adult hereditary cancer testing in Ontario. J. Med. Genet. 60, 769\u2013775 (2023).","journal-title":"J. Med. Genet."},{"key":"476_CR10","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13039-020-00522-1","volume":"14","author":"B Durak Aras","year":"2021","unstructured":"Durak Aras, B. et al. Which prognostic marker is responsible for the clinical heterogeneity in CLL with 13q deletion?. Mol. Cytogenet. 14, 1\u20137 (2021).","journal-title":"Mol. Cytogenet."},{"key":"476_CR11","doi-asserted-by":"publisher","first-page":"2269","DOI":"10.1007\/s00277-018-3503-6","volume":"97","author":"V Buccheri","year":"2018","unstructured":"Buccheri, V. et al. Prognostic and therapeutic stratification in CLL: focus on 17p deletion and p53 mutation. Ann. Hematol. 97, 2269\u20132278 (2018).","journal-title":"Ann. Hematol."},{"key":"476_CR12","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1016\/j.beha.2013.09.004","volume":"26","author":"A Giagounidis","year":"2013","unstructured":"Giagounidis, A. & Haase, D. Morphology, cytogenetics and classification of MDS. Best. Pract. Res. Clin. Haematol. 26, 337\u2013353 (2013).","journal-title":"Best. Pract. Res. Clin. Haematol."},{"key":"476_CR13","doi-asserted-by":"publisher","first-page":"1049","DOI":"10.1182\/blood-2018-10-844621","volume":"133","author":"S Ogawa","year":"2019","unstructured":"Ogawa, S. Genetics of MDS. Blood 133, 1049\u20131059 (2019).","journal-title":"Blood"},{"key":"476_CR14","doi-asserted-by":"publisher","first-page":"872","DOI":"10.1001\/jama.2022.14578","volume":"328","author":"MA Sekeres","year":"2022","unstructured":"Sekeres, M. A. & Taylor, J. Diagnosis and treatment of myelodysplastic syndromes: a review. JAMA 328, 872\u2013880 (2022).","journal-title":"JAMA"},{"key":"476_CR15","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1016\/j.beha.2013.10.013","volume":"26","author":"RS Komrokji","year":"2013","unstructured":"Komrokji, R. S., Padron, E., Ebert, B. L. & List, A. F. Deletion 5q MDS: Molecular and therapeutic implications. Best. Pract. Res. Clin. Haematol. 26, 365\u2013375 (2013).","journal-title":"Best. Pract. Res. Clin. Haematol."},{"key":"476_CR16","doi-asserted-by":"publisher","first-page":"2779","DOI":"10.1038\/s41375-019-0617-3","volume":"33","author":"Y Nagata","year":"2019","unstructured":"Nagata, Y. & Maciejewski, J. P. The functional mechanisms of mutations in myelodysplastic syndrome. Leukemia 33, 2779\u20132794 (2019).","journal-title":"Leukemia"},{"key":"476_CR17","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1309\/AJCPBADO22WXOFHJ","volume":"144","author":"G Tang","year":"2015","unstructured":"Tang, G. et al. Isolated del(5q) in patients following therapies for various malignancies may not all be clinically significant. Am. J. Clin. Pathol. 144, 78\u201386 (2015).","journal-title":"Am. J. Clin. Pathol."},{"key":"476_CR18","doi-asserted-by":"publisher","first-page":"2747","DOI":"10.1093\/bioinformatics\/bts526","volume":"28","author":"V Plagnol","year":"2012","unstructured":"Plagnol, V. et al. A robust model for read count data in exome sequencing experiments and implications for copy number variant calling. Bioinformatics 28, 2747 (2012).","journal-title":"Bioinformatics"},{"key":"476_CR19","doi-asserted-by":"publisher","first-page":"2422","DOI":"10.1056\/NEJMoa2300503","volume":"388","author":"EA DeBoy","year":"2023","unstructured":"DeBoy, E. A. et al. Familial clonal hematopoiesis in a long telomere syndrome. N. Engl. J. Med. 388, 2422\u20132433 (2023).","journal-title":"N. Engl. J. Med."},{"key":"476_CR20","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1038\/s41431-021-01013-6","volume":"30","author":"A McGuigan","year":"2022","unstructured":"McGuigan, A. et al. Multilocus inherited neoplasia allele syndrome (MINAS): an update. Eur. J. Hum. Genet. 30, 265\u2013270 (2022).","journal-title":"Eur. J. Hum. Genet."},{"key":"476_CR21","doi-asserted-by":"publisher","first-page":"1142","DOI":"10.1038\/s41436-020-0783-8","volume":"22","author":"MM Li","year":"2020","unstructured":"Li, M. M. et al. Points to consider for reporting of germline variation in patients undergoing tumor testing: a statement of the American College of Medical Genetics and Genomics (ACMG). Genet. Med. 22, 1142\u20131148 (2020).","journal-title":"Genet. Med."},{"key":"476_CR22","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1515\/jtim-2017-0002","volume":"5","author":"M Hong","year":"2017","unstructured":"Hong, M. & He, G. The 2016 Revision to the World Health Organization classification of myelodysplastic syndromes. J. Transl. Int. Med. 5, 139 (2017).","journal-title":"J. Transl. Int. Med."},{"key":"476_CR23","doi-asserted-by":"publisher","first-page":"950","DOI":"10.1002\/humu.24374","volume":"43","author":"L DeRoin","year":"2022","unstructured":"DeRoin, L. et al. Feasibility and limitations of cultured skin fibroblasts for germline genetic testing in hematologic disorders. Hum. Mutat. 43, 950\u2013962 (2022).","journal-title":"Hum. Mutat."},{"key":"476_CR24","doi-asserted-by":"publisher","first-page":"809","DOI":"10.1038\/gim.2017.196","volume":"20","author":"JN Weitzel","year":"2018","unstructured":"Weitzel, J. N. et al. Somatic TP53 variants frequently confound germ-line testing results. Genet. Med. 20, 809\u2013816 (2018).","journal-title":"Genet. Med."},{"key":"476_CR25","doi-asserted-by":"publisher","first-page":"664","DOI":"10.1002\/cncr.31185","volume":"124","author":"RD Webster","year":"2018","unstructured":"Webster, R. D., Ross, J. L. & Arun, B. K. The changing landscape of hereditary cancer genetic testing. Cancer 124, 664\u2013666 (2018).","journal-title":"Cancer"},{"key":"476_CR26","doi-asserted-by":"publisher","first-page":"961128","DOI":"10.3389\/fdgth.2022.961128","volume":"4","author":"EJ Dusic","year":"2022","unstructured":"Dusic, E. J., Theoryn, T., Wang, C., Swisher, E. M. & Bowen, D. J. Barriers, interventions, and recommendations: improving the genetic testing landscape. Front. Digit. Health 4, 961128 (2022).","journal-title":"Front. Digit. Health"},{"key":"476_CR27","doi-asserted-by":"crossref","unstructured":"Gagnier, J. J. et al. The CARE guidelines: consensus-based clinical case reporting guideline development. Glob. Adv. Health Med. 2, 38\u201343 (2013).","DOI":"10.7453\/gahmj.2013.008"},{"key":"476_CR28","doi-asserted-by":"publisher","first-page":"1281","DOI":"10.1182\/bloodadvances.2023011735","volume":"8","author":"MB Davidson","year":"2024","unstructured":"Davidson, M. B. et al. Outcomes of intensive and nonintensive blast-reduction strategies in accelerated and blast-phase MPN. Blood Adv. 8, 1281\u20131294 (2024).","journal-title":"Blood Adv."}],"container-title":["npj Genomic Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41525-025-00476-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41525-025-00476-6","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41525-025-00476-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,14]],"date-time":"2025-05-14T23:59:02Z","timestamp":1747267142000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41525-025-00476-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5,15]]},"references-count":28,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["476"],"URL":"https:\/\/doi.org\/10.1038\/s41525-025-00476-6","relation":{},"ISSN":["2056-7944"],"issn-type":[{"value":"2056-7944","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,5,15]]},"assertion":[{"value":"16 August 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 February 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 May 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"39"}}